RT Journal Article
SR Electronic
T1 High-flow support in very preterm infants in Australia and New Zealand
JF Archives of Disease in Childhood - Fetal and Neonatal Edition
JO Arch Dis Child Fetal Neonatal Ed
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP F401
OP F403
DO 10.1136/archdischild-2015-309328
VO 101
IS 5
A1 C T Roberts
A1 L S Owen
A1 B J Manley
A1 P G Davis
YR 2016
UL http://fn.bmj.com/content/101/5/F401.abstract
AB Background Randomised trials suggest that high-flow (HF) therapy is comparable with continuous positive airway pressure (CPAP) for postextubation respiratory support in neonates, and HF has been widely adopted in neonatal intensive care.Methods We conducted a population-based study of very preterm infants born <32 weeks’ gestation within the Australian and New Zealand Neonatal Network (ANZNN) data set from 2009 to 2012, who received respiratory support with HF.Results 3372 very preterm infants were treated with HF. HF use in this population increased significantly from 15% in 2009 to 35% in 2012. In 2012, 53% (542/1029) of extremely preterm infants born <28 weeks’ gestation received HF. 98% (3308/3372) of infants had received endotracheal ventilation or CPAP prior to receiving HF. The maximum HF gas flow was ≤8 L/min in almost all infants.Conclusions HF use in extremely preterm and very preterm infants increased significantly within the ANZNN from 2009 to 2012.